CDC study finds RSV vaccines protect older adults from hospitalization
![stock-injection-needle_900x400](/sites/default/files/styles/900x400/public/2018-02/stock-injection-needle_900x400.jpg?itok=ATX5ju3c)
The Centers for Disease Control and Prevention Sept. 4 published a study in JAMA which found older adults who receive a respiratory syncytial virus vaccine are 75% less likely to be hospitalized from RSV compared to those who don’t. The CDC last month updated RSV vaccine guidance for adults 60 and older, recommending those aged 60-74 at risk for RSV and all aged 75 and older receive one dose of the GSK, Pfizer or Moderna vaccine. Those who previously received a dosage should not seek another.
Related News Articles
Headline
The Centers for Disease Control and Prevention May 29 published a blog co-authored by AHA, the National Institute for Occupational Safety and Health and the…
Blog
Our health may be the most personal and important thing we have. It determines how we feel when we wake up in the morning, how we relate to our families and…
Blog
Exploring and developing a better understanding of the social determinants of health is becoming standard in medical education and training. Social isolation…
Chairperson's File
In today’s episode, I talk with Lynn Todman, vice president of health equity and community partnerships at Corewell Health. Our discussion focuses on the many…
Blog
As a pediatrician, I've seen the impact of pediatric sepsis firsthand — it's an aggressive and unrelenting adversary that knows neither geographic nor…
Headline
The House Energy and Commerce Health Subcommittee March 12 passed AHA-supported legislation to reauthorize through 2029 the Dr. Lorna Breen Health Care…